King, E. A., Davis, J. W., & Degner, J. F. (2019). Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS genetics, 15(12), e1008489. https://doi.org/10.1371/journal.pgen.1008489
Citace podle Chicago (17th ed.)King, Emily A., J. Wade Davis, a Jacob F. Degner. "Are Drug Targets with Genetic Support Twice as Likely to Be Approved? Revised Estimates of the Impact of Genetic Support for Drug Mechanisms on the Probability of Drug Approval." PLoS Genetics 15, no. 12 (2019): e1008489. https://doi.org/10.1371/journal.pgen.1008489.
Citace podle MLA (9th ed.)King, Emily A., et al. "Are Drug Targets with Genetic Support Twice as Likely to Be Approved? Revised Estimates of the Impact of Genetic Support for Drug Mechanisms on the Probability of Drug Approval." PLoS Genetics, vol. 15, no. 12, 2019, p. e1008489, https://doi.org/10.1371/journal.pgen.1008489.